Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide is a GIP/GLP-1 dual agonist, engaging two receptor pathways, while semaglutide is a single-target GLP-1 receptor agonist
The Digestive Learner: You have noticed that your body doesn't handle certain foods as well as it used to, and you want to support your intestinal health
Recognized as a top 1% most cited article in its field, it has become a foundational reference driving the repurposing of antidiabetic drugs in neurology
Although it was originally FDA-approved to treat type 2 diabetes, tirzepatide has also been prescribed off-label to support weight loss efforts
US$ 29.73
US$ 21.27
US$ 20.95
US$ 21.17
US$ 26.14
